Press release
Drug-Delivery Technology Market Research Explores Growth Within A $91.41 Billion Opportunity
Drug-Delivery Technology Market
Projected Growth and Market Size of the Drug-Delivery Technology Market
The drug-delivery technology market has seen rapid expansion in recent years. It is anticipated to increase from $54.24 billion in 2025 to $60.27 billion in 2026, growing at a compound annual growth rate (CAGR) of 11.1%. This historical growth can be linked to the rising prevalence of chronic diseases, progress in pharmaceutical formulations, greater demand for improved patient adherence, the spread of injectable therapies, and innovations in medical devices. Looking ahead, the market is expected to continue this momentum, reaching $91.41 billion by 2030 with a CAGR of 11.0%. Factors fueling this future growth include the rise of personalized medicine, expansion in biologics and biosimilars, a growing appetite for long-acting drug delivery systems, technological advancements in implantables, and the increasing adoption of home care treatments. Emerging trends such as targeted drug delivery, controlled and sustained release formulations, patient-centric devices, minimally invasive technologies, and advanced implantable drug systems are poised to shape the market landscape.
Top Companies Driving the Drug-Delivery Technology Market
Several key players currently lead the drug-delivery technology market. These include Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi S.A., AstraZeneca Plc, Novartis AG, GlaxoSmithKline Plc., Cipla Limited, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Vertex Pharmaceuticals Incorporated, Chiesi Farmaceutici S.p.A., United Therapeutics Corporation, Mallinckrodt Pharmaceuticals Plc., Lupin Pharmaceuticals, Inc., Glenmark Pharmaceuticals Limited, Alkermes plc., Halozyme Therapeutics Inc., Sunovion Pharmaceuticals Inc., and Circassia Pharmaceuticals Plc. In a notable move in January 2025, Molex, a US-based supplier of electronic interconnect and packaging solutions through its Phillips Medisize subsidiary, acquired Vectura Group Ltd., a UK company specializing in inhalation drug-device design and development. This acquisition aims to broaden Molex/Phillips Medisize's portfolio by incorporating Vectura's expertise in inhalation formulations and device development, enhancing capabilities in respiratory and combination therapies.
Download a free sample of the drug-delivery technology market report:
https://thebusinessresearchcompany.com/sample_request?id=85376447&type=smp&name=Drug-Delivery%20Technology%20Market%20Report%202026&utm_source=OpenPR&utm_medium=paid&utm_campaign=Sep_PR
Innovations Enhancing Patient Care in Drug Delivery
Leading companies in this sector are placing strong emphasis on the development of innovative products that enhance patient convenience and safety. Prefilled injection devices are gaining particular attention, as they come preloaded with a specific medication dose, reducing errors and simplifying administration. For example, in February 2023, Phillips-Medisize LLC introduced a disposable pen injector designed for high-volume manufacturing. The device features a compact, adaptable design with customizable dosing and push-button colors to support various therapies including diabetes, fertility, growth hormones, obesity, and osteoporosis. This innovation aims to help pharmaceutical companies bring products to market faster and more cost-effectively while minimizing commercialization risks.
Market Segmentation and Leading Categories in Drug-Delivery Technology
The drug-delivery technology market is categorized by type, application, and end user. By type, it includes oral, injectable, topical, ocular, nasal, pulmonary, transmucosal, and implantable delivery methods. Applications cover cardiovascular diseases, oncology, urology, diabetes, central nervous system disorders, ophthalmology, infections, and other medical areas. End users range from hospitals and clinics to diagnostic centers and home care settings. Subsegments under these categories explore various forms such as tablets, capsules, and gels in oral delivery; conventional, self, and long-acting injections; creams, patches, and ointments for topical use; eye drops and implants for ocular delivery; nasal sprays and powders; metered dose inhalers, dry powder inhalers, and nebulizers in pulmonary delivery; buccal, sublingual, rectal, and vaginal routes for transmucosal delivery; and biodegradable and non-biodegradable implants including drug-eluting stents.
View the full drug-delivery technology market report:
https://thebusinessresearchcompany.com/report/drug-delivery-technology-global-market-report?utm_source=OpenPR&utm_medium=paid&utm_campaign=Sep_PR
This detailed segmentation provides a clearer picture of how the drug-delivery technology market is organized and highlights the diverse product types and applications driving its robust growth through 2030.
The 2026 edition of our market reports now delivers enhanced analytical coverage through market attractiveness scoring and analysis, total addressable market (TAM) analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, plus updated graphics and tables.
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Drug-Delivery Technology Market Research Explores Growth Within A $91.41 Billion Opportunity here
News-ID: 4640895 • Views: …
More Releases from The Business Research Company
Critical Communication Market Report Examines Leading Companies And Growth Oppor …
The critical communication sector has experienced swift growth recently, driven by rising demand for dependable and secure communication solutions, especially in public safety and emergency response. As technology advances and infrastructure investments increase, this market is set for continued expansion through 2030. Let's explore the market's current size, key growth drivers, leading players, emerging trends, and segmentation details to understand its future outlook.
Long-Term Market Growth Expectations for Critical Communication …
Corporate Web Security Market Insights Highlight Segment Expansion And Market Le …
The corporate web security market is witnessing remarkable growth as organizations increasingly prioritize protecting their digital assets from evolving cyber threats. With rising internet usage and more sophisticated attacks, companies are investing heavily in advanced security measures to safeguard their networks and data. Let's explore the current market status, key players, major trends, and the segments driving this sector's expansion.
Corporate Web Security Market Size and Growth Outlook
The corporate…
Converged Cable Access Platform (CCAP) Market Intelligence Report Covers Trends, …
The converged cable access platform (CCAP) market has experienced swift expansion recently, driven by the growing demand for enhanced cable broadband networks and advanced digital services. As connectivity needs continue to surge, the market is set for further significant growth in the coming years, fueled by technological advancements and increasing investments. Let us explore the current market size, key players, major trends, and the segmentation shaping the future of this…
Container Orchestration Market Demonstrates Long-Term Growth Potential At 19.7% …
The container orchestration market has witnessed remarkable expansion recently, driven by the increasing adoption of containerized applications and modern infrastructure strategies. As organizations continue to embrace cloud-native technologies and automation, this market is set to experience even more substantial growth in the coming years. Let's explore the current market size, key players, emerging trends, and significant segments shaping the future of container orchestration.
Projected Growth Trajectory of the Container Orchestration Market…
More Releases for Drug
Injectable Drug Delivery Market Injectable Drug Delivery Market
Leading market research firm SkyQuest Technology Group recently released a study titled ' Injectable Drug Delivery Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Injectable Drug Delivery report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Injectable Drug Delivery Market extensively demonstrates existing and upcoming…
Global Advanced Drug Delivery Systems Market Size - By Product Type(Oral Drug De …
Market Overview and Report Coverage
Advanced Drug Delivery Systems (ADDS) refer to innovative technologies designed to improve the administration and efficacy of therapeutics, enhancing the way medications are delivered to targeted areas within the body. These systems aim to optimize treatment outcomes by increasing the bioavailability, reducing side effects, and facilitating controlled drug release. Employing methods such as nanoparticles, liposomes, and implantable pumps, ADDS are revolutionizing personalized medicine and expanding therapeutic…
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Pric …
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Price, and Clinical Trials Outlook 2029 Report Highlights:
* Global Antibody Drug Conjugates Market Opportunity: > 40 Billion By 2029
* Global and Regional Antibody Drug Conjugate Market Insight
* Approved Drugs Sales Insight Global and Regional, Yearly and Quarterly, 2019 -2023
* Approved Antibody Drug Conjugates - Availability, Dosage and Price Insight
* Insight On Antibody Drug Conjugates In Clinical Trials: > 550…
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions.
Alcohol abuse and drug…
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.
Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes…
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Hepatitis Disease
1.1 Prologue
1.1.1 History of Hepatitis
1.1.2 Causes of Hepatitis Disease
1.2 Types of Viruses which are Responsible for Hepatitis Disease
2. Global Prevalence of Hepatitis Infection
3. Available Drug Classes for Hepatitis Disease Treatment
3.1 Interferon Alfa Therapy
3.2 Protease Inhibitors Therapy
3.3 Polymerase…
